Bruker Corporation has announced the launch of their new timsUltra AIP System, a groundbreaking advancement designed to enhance the sensitivity and capabilities of single-cell proteomics, FNA biopsy immunopeptidomics, and metaproteomics research. This innovative system allows scientists to explore life and materials at molecular, cellular, and microscopic levels with unprecedented precision. The timsUltra AIP System represents a significant leap in post-genomic life science research, supporting applications in preclinical imaging, clinical phenomics, proteomics, and multiomics. By providing high performance scientific instruments and analytical solutions, Bruker continues to facilitate innovation and improved productivity in fields such as molecular and cell biology, microscopy, and next-gen semiconductor metrology, ultimately contributing to advancements in human health and technology.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。